Biostatistics • Probability & Distributions

Poisson Distribution — Use Poisson distribution for rare events and incidence

Model the probability of rare, independent events occurring in fixed intervals of time, space, or population exposure.

A scatter plot connecting biological data with a DNA strand and health signal.
Inside this lesson 10 sections 5 questions 9 figures

SECTION 1

Historical Context & Motivation

The mathematical foundations of the Poisson distribution emerged from a surprisingly practical question: how do you predict the occurrence of events that happen rarely, seemingly at random, yet with a stable average rate over time? Before its formalization, mathematicians and scientists struggled to describe phenomena such as the number of deaths from horse kicks in Prussian army corps per year, the number of misprints per page in a book, or the arrival of customers at a service counter during a fixed period. These events share a common structure — they are individually unlikely at any given instant, yet collectively they follow a remarkably predictable pattern when observed over many intervals.

The need for such a distribution became apparent as the binomial distribution — the workhorse of discrete probability at the time — proved computationally unwieldy when the number of trials n was very large and the probability of success p was very small. Scientists needed a more elegant limiting form that could capture the essence of rare-event counting without requiring enormous factorial computations. The Poisson distribution filled this gap, and its applications in epidemiology, genetics, public health, and clinical research have made it one of the most important tools in modern biostatistics.

1837 • Poisson's Treatise

Siméon Denis Poisson published Recherches sur la probabilité des jugements, introducing the distribution as a limiting case of the binomial, though the work received relatively little attention at the time.

1898 • Bortkiewicz & Prussian Horse Kicks

Ladislaus Bortkiewicz demonstrated the distribution's practical power by modeling deaths from horse kicks in 14 Prussian army corps over 20 years — a now-classic dataset that validated the Poisson model for rare events.

1910s • Adoption in Biology & Medicine

Researchers began applying Poisson models to bacterial colony counts, radioactive decay events, and mutation rates, establishing the distribution as foundational in biostatistics and the life sciences.

1946 • Luria–Delbrück Experiment

Salvador Luria and Max Delbrück used deviations from Poisson predictions to prove that bacterial mutations arise spontaneously rather than in response to selection, earning a Nobel Prize and cementing the distribution's role in genetics.

Modern Era • Epidemiological Surveillance

Poisson regression and Poisson-based models are now standard in disease surveillance, spatial epidemiology, pharmacovigilance (monitoring adverse drug reactions), and genomic sequencing analysis.

The central question the Poisson distribution addresses is deceptively simple: given a known average rate of occurrence, what is the probability of observing exactly k events in a fixed interval? This question arises constantly in biostatistics — from counting the number of new cancer diagnoses in a region per month to tracking adverse events in a clinical trial — and understanding the distribution's assumptions, derivation, and limitations is essential for any rigorous analysis of incidence data.

SECTION 2

Core Principles & Definitions

The Poisson distribution is a discrete probability distribution that expresses the probability of a given number of events occurring in a fixed interval of time, space, area, or volume, provided these events occur with a known constant mean rate and independently of one another. It is completely characterized by a single parameter, λ (lambda), which represents both the expected value (mean) and the variance of the distribution. This elegant property — the equality of mean and variance, known as equidispersion — serves as both a defining characteristic and a diagnostic criterion for assessing whether a Poisson model is appropriate for a given dataset.

1

Events Are Independent

The occurrence of one event does not influence the probability of another. For example, one patient developing an adverse reaction does not change the likelihood of a different patient doing so (no clustering or contagion effects).
2

Constant Average Rate

The mean rate λ remains stable across equal-sized intervals. If, on average, 3 cases of a disease occur per month, that rate should hold across months — there should be no seasonal or temporal trends violating this constancy.
3

Events Are Rare Relative to Opportunities

In any infinitesimally small sub-interval, the probability of more than one event occurring is negligible. Two events do not happen simultaneously; each event occupies its own distinct point in time or space.
4

Proportionality to Interval Size

The probability of an event in a small sub-interval is proportional to the length (or size) of that sub-interval. Doubling the observation window doubles the expected count: if λ = 4 per hour, then λ = 8 per two hours.
✦

KEY TAKEAWAY

Think of the Poisson distribution as a model for counting needles in a haystack. Each needle (event) is rare, lands independently of others, and the haystack (observation interval) provides an enormous number of 'slots' where a needle could appear. You don't track each slot individually — you simply count total needles. The Poisson distribution tells you the probability of finding exactly k needles if you know that, on average, λ needles are present. In biostatistics, the 'needles' might be disease cases, mutations, or adverse drug events, and the 'haystack' is your population-time at risk.

SECTION 3

Visualizing the Poisson Distribution

The shape of the Poisson probability mass function (PMF) changes dramatically as λ increases. For small values of λ (say, λ = 1 or 2), the distribution is strongly right-skewed, with the highest probability concentrated at k = 0 or k = 1 and a long tail extending toward higher counts. As λ grows, the distribution becomes more symmetric, gradually approximating a normal distribution — a property that becomes practically useful for λ ≥ 20 or so. The diagram below illustrates three different Poisson distributions overlaid on the same axis to highlight how the parameter λ controls both the center and the spread of the distribution.

Poisson PMF for λ = 1, λ = 4, λ = 8Number of events (k)P(X = k)01234567891011121300.100.200.300.40λ = 1 (right-skewed)λ = 4 (moderate skew)λ = 8 (near-symmetric)
Poisson probability mass functions for three values of λ. At λ = 1 (violet), the distribution peaks near zero and is strongly right-skewed. At λ = 4 (cyan), the peak shifts right and the spread increases. At λ = 8 (pink), the distribution approaches symmetry, beginning to resemble a normal curve.

Several features of the diagram deserve attention. First, notice that the mode (tallest bar) of each distribution lies near λ — specifically at ⌊λ⌋ for non-integer λ — confirming that λ is indeed the center of the distribution. Second, as λ increases, the bars spread out; this reflects the fact that the standard deviation of a Poisson random variable is √λ, so larger rates produce wider distributions. Third, for small λ, P(X = 0) is the single most probable outcome, which is critically important in biostatistics: if a rare disease has an incidence rate of λ = 0.5 cases per hospital per year, the most likely observation in any given year is zero cases. This counterintuitive result often surprises clinicians but is a direct consequence of the Poisson framework.

SECTION 4

Mathematical Framework

The Poisson distribution can be derived as a limiting case of the binomial distribution when the number of trials n → ∞ and the success probability p → 0 such that the product np = λ remains constant. This derivation reveals why the Poisson distribution is the natural model for rare events: it is the result of splitting a fixed interval into an ever-increasing number of sub-intervals, each with an ever-decreasing probability of containing an event, while the overall expected count stays fixed.

POISSON PROBABILITY MASS FUNCTION

P(X=k)=(e−λ×λk)/k!P(X = k) = (e⁻λ × λᵏ) / k!

Where X is the Poisson random variable, k = 0, 1, 2, … is the number of observed events, λ > 0 is the expected number of events per interval, e ≈ 2.71828 is Euler's number, and k! is the factorial of k.

MEAN AND VARIANCE

E(X)=λVar(X)=λE(X) = λ Var(X) = λ

The Poisson distribution's defining property: the mean equals the variance. If observed data show Var(X) ≫ λ (overdispersion) or Var(X) ≪ λ (underdispersion), the Poisson model may be inappropriate.

CUMULATIVE PROBABILITY

P(X≤k)=e−λ×Σi=0k(λi/i!)P(X ≤ k) = e⁻λ × Σᵢ₌₀ᵏ (λⁱ / i!)

The cumulative distribution function (CDF) gives the probability of observing at most k events. In biostatistics, this is frequently used to determine whether an observed count is unusually high — for example, testing whether a disease cluster exceeds expected incidence.

BINOMIAL-TO-POISSON LIMIT

lim(n→∞)C(n,k)×pk×(1−p)n−k=(e−λ×λk)/k!whereλ=nplim(n→∞) C(n,k) × pᵏ × (1−p)ⁿ⁻ᵏ = (e⁻λ × λᵏ) / k! where λ = np

This limit shows formally that the Poisson distribution arises whenever n is large, p is small, and the product np remains moderate. A common rule of thumb: use the Poisson approximation when n ≥ 20 and p ≤ 0.05, or when n ≥ 100 and np ≤ 10.

ℹ

Person-Time and Rate Parameter

In epidemiology, λ is often expressed as a product of the incidence rate (r) and the person-time at risk (T), so that λ = r × T. For example, if a disease incidence rate is 0.002 per person-year and you follow 5,000 individuals for one year, then λ = 0.002 × 5000 = 10 expected cases. This formulation is central to Poisson regression and standardized incidence ratio (SIR) calculations.

SECTION 5

Applications in Biostatistics & Epidemiology

The Poisson distribution finds its most natural home in biostatistics wherever researchers need to model counts of rare, independent events occurring over a defined exposure period or within a defined population. Its applications range from counting mutations per genome to estimating disease incidence per 100,000 person-years. Below is a classification of common biostatistical applications, each illustrating how the Poisson assumptions map onto real-world phenomena.

Poisson Distribution: Biostatistical Applications MapPOISSON MODELEPIDEMIOLOGYGENETICS & BIOLOGYCLINICAL TRIALSDisease Incidence CountsCases per region per timeCluster DetectionIs observed count > expected?Mortality SurveillanceDeaths per hospital per monthMutation CountingSNPs per gene regionBacterial Colony CountsColonies per Petri dishCrossover EventsRecombination per chromosomeAdverse Event MonitoringReactions per 1000 patientsRare Endpoint AnalysisDeaths, organ failures, etc.Sample Size PlanningExpected events for power calcCommon Thread: All applications involve independent, rare events with a stable mean rate λover a well-defined interval of time, space, or population exposure.
Hierarchical map of Poisson distribution applications across three major domains of biostatistics: epidemiology, genetics and biology, and clinical trials. Each branch illustrates specific counting scenarios where Poisson assumptions hold.
ApplicationEvent CountedInterval / ExposureTypical λ
Cancer incidenceNew cancer casesPer 100,000 person-years5–50
Nosocomial infectionsHospital-acquired infectionsPer 1,000 patient-days2–10
Somatic mutationsPoint mutationsPer megabase of DNA0.5–20
Adverse drug reactionsSerious adverse eventsPer 10,000 treated patients1–5
Bacterial coloniesColony-forming unitsPer mL of sample10–200

Representative biostatistical applications with typical lambda values

SECTION 6

Worked Example: Disease Incidence in a Hospital

Consider the following scenario: a hospital infection control team tracks methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections across its intensive care unit. Historical data show an average of λ = 3 infections per month. During a recent month, the unit recorded 6 infections. The team wants to determine: (a) the probability of observing exactly 6 infections in a month, and (b) the probability of observing 6 or more infections, to assess whether this count warrants an outbreak investigation.

MRSA Bloodstream Infections — Poisson Probability Calculation

  1. 1

    Step 1 — Identify the Parameters

    The average rate is λ = 3 infections per month. We want P(X = 6), where X follows a Poisson distribution with parameter λ = 3. The observation interval is exactly one month, matching the time frame over which λ was estimated.
    λ = 3, k = 6
  2. 2

    Step 2 — Apply the PMF Formula

    Substituting into the Poisson PMF: P(X = 6) = (e⁻³ × 3⁶) / 6!. We compute each component: e⁻³ ≈ 0.04979, 3⁶ = 729, and 6! = 720.
    P(X = 6) = (0.04979 × 729) / 720
  3. 3

    Step 3 — Calculate the Exact Probability

    Numerator: 0.04979 × 729 = 36.297. Dividing by 720: P(X = 6) = 36.297 / 720 ≈ 0.0504. So there is approximately a 5.0% chance of observing exactly 6 infections in any given month under the assumed Poisson model.
    P(X = 6) ≈ 0.0504 (5.04%)
  4. 4

    Step 4 — Compute the Tail Probability P(X ≥ 6)

    To determine whether 6 infections is unusually high, we compute P(X ≥ 6) = 1 − P(X ≤ 5). Using the cumulative formula or a Poisson table: P(X ≤ 5) = P(0) + P(1) + P(2) + P(3) + P(4) + P(5) = 0.0498 + 0.1494 + 0.2240 + 0.2240 + 0.1680 + 0.1008 = 0.9161.
    P(X ≤ 5) ≈ 0.9161
  5. 5

    Step 5 — Interpret the Result

    Therefore, P(X ≥ 6) = 1 − 0.9161 = 0.0839, or about 8.4%. This means that if the true underlying rate were indeed 3 per month, there would be roughly an 8.4% chance of observing 6 or more infections in any given month. Many infection control programs use a threshold of α = 0.05; since 0.084 > 0.05, this single month's observation does not quite reach conventional statistical significance, though it would warrant close monitoring in subsequent months.
    P(X ≥ 6) ≈ 0.0839 (8.39%) — elevated but not statistically significant at α = 0.05
💡

Clinical Interpretation Note

Statistical significance is not the same as clinical importance. Even though 6 MRSA infections does not cross the 5% threshold in a single month, the infection control team might still investigate if the count remains elevated over consecutive months. Poisson-based CUSUM charts (cumulative sum control charts) are used in practice to detect sustained shifts in rates that individual monthly tests might miss.

SECTION 7

Strengths, Limitations, and Diagnostic Checks

The Poisson distribution's elegance — a single parameter governing both the mean and the variance — is simultaneously its greatest strength and most restrictive assumption. In practice, real-world count data frequently exhibit overdispersion, where the observed variance exceeds the mean, violating the equidispersion assumption. Understanding when the Poisson model is appropriate and when alternatives should be considered is essential for rigorous biostatistical analysis.

StrengthsLimitations
Only one parameter (λ) to estimate — parsimonious and easy to fitRequires mean = variance (equidispersion), which is often violated in biological data
Analytically tractable: closed-form PMF, CDF, and moment-generating functionAssumes independence of events — fails when contagion, clustering, or correlation exists
Natural model for count data with no upper boundDoes not handle excess zeros well (use zero-inflated Poisson instead)
Straightforward extension to regression (Poisson GLM with log link)Constant rate assumption is unrealistic for time-varying or seasonal processes
Serves as the foundation for more complex models (negative binomial, mixed Poisson)Tail probabilities can be unreliable for very small λ when sample sizes are small

Strengths and limitations of the Poisson distribution in biostatistical applications

🔍

DIAGNOSTIC RULE OF THUMB

Before fitting a Poisson model, compute the variance-to-mean ratio (VMR) of your count data, also called the index of dispersion. If VMR ≈ 1, the Poisson model is appropriate. If VMR > 1 (overdispersion), consider the negative binomial distribution or a quasi-Poisson model. If VMR < 1 (underdispersion), the data may be more regular than random — consider a binomial or generalized Poisson model. Think of the VMR as the Poisson model's 'blood pressure check' — it takes only seconds and can prevent a misdiagnosis.

SECTION 8

Connection to Advanced Models

The Poisson distribution does not exist in isolation; it serves as the foundation for a family of increasingly sophisticated models used throughout biostatistics. Understanding where the basic Poisson model sits in this hierarchy helps you select the right tool for a given research question and recognize when a more flexible approach is necessary.

FeatureBasic PoissonPoisson Regression (GLM)Negative Binomial
Parametersλ onlyβ coefficients via log-link; λ = exp(Xβ)μ (mean) and θ (dispersion)
Variance structureVar = μVar = μ (assumed)Var = μ + μ²/θ (> μ)
CovariatesNone (single rate)Multiple predictors (age, exposure, treatment)Multiple predictors with extra dispersion
Handles overdispersionNoNo (use quasi-Poisson for SE adjustment)Yes — the primary reason for choosing it
Typical use caseQuick probability calculation; initial model fitIncidence rate ratios; adjusted disease mappingRNA-seq count data; clustered disease counts

Comparison of Poisson-family models commonly used in biostatistics

Beyond these models, the Poisson distribution connects to several advanced topics you may encounter in graduate-level biostatistics. The Poisson process — a continuous-time stochastic process — extends the distribution to model not just how many events occur, but when they occur. The inter-event times in a Poisson process follow an exponential distribution with rate parameter λ, providing a bridge between discrete count models and continuous survival analysis. Additionally, zero-inflated Poisson (ZIP) models accommodate datasets with more zeros than a standard Poisson predicts — common in health surveys where many individuals report zero hospital visits — by mixing a Poisson distribution with a point mass at zero. These extensions demonstrate the fundamental role of the Poisson distribution as a building block for the entire generalized linear model framework in biostatistics.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

A researcher claims that the Poisson distribution is appropriate for modeling the number of car accidents at a busy intersection per day. However, she notes that accidents tend to increase during heavy rainfall and cluster around rush hours. Identify which Poisson assumption(s) this scenario likely violates and explain why.
Show answer
This scenario likely violates two key Poisson assumptions. First, the constant rate assumption is violated because the accident rate changes with weather conditions (rainfall increases risk) and time of day (rush hours produce higher traffic volume), meaning λ is not stable across all intervals of the day or all days of the year. Second, the independence assumption may be violated because one accident can cause rubbernecking or road blockages that increase the probability of subsequent accidents in the same time window. A time-varying Poisson model or a negative binomial model accounting for overdispersion would be more appropriate.

Question 2: BASIC CALCULATION

A public health laboratory receives an average of λ = 2 contaminated water samples per week. Assuming a Poisson distribution, calculate the probability that the laboratory receives exactly 4 contaminated samples in a given week.
Show answer
Using the Poisson PMF: P(X = 4) = (e⁻² × 2⁴) / 4! = (0.13534 × 16) / 24 = 2.16536 / 24 ≈ 0.0902. There is approximately a 9.02% probability of receiving exactly 4 contaminated samples in a given week. Note how the probability decreases as we move away from the mean (λ = 2), reflecting the right-skewed nature of the distribution at small λ values.

Question 3: INTERMEDIATE

A rare genetic disorder occurs at a rate of 1 in 10,000 births. In a city where 50,000 babies are born in a year, use the Poisson approximation to: (a) determine the expected number of cases per year, and (b) calculate the probability that fewer than 3 cases are observed in a year.
Show answer
(a) With n = 50,000 and p = 1/10,000 = 0.0001, the expected count is λ = np = 50,000 × 0.0001 = 5 cases per year. (b) P(X < 3) = P(X = 0) + P(X = 1) + P(X = 2). Calculating each: P(0) = e⁻⁵ × 5⁰/0! = 0.00674, P(1) = e⁻⁵ × 5¹/1! = 0.03369, P(2) = e⁻⁵ × 5²/2! = 0.08422. Summing: P(X < 3) = 0.00674 + 0.03369 + 0.08422 = 0.1247, or about 12.5%. This tells us that observing 0, 1, or 2 cases in a year would occur roughly 1 in 8 years under this model — unusual but not extremely rare.

Question 4: APPLIED

A pharmacovigilance team monitors a new drug for severe allergic reactions. Based on pre-market clinical trials, the expected rate is λ = 1.5 reactions per 10,000 patient-months of exposure. After the drug is approved, 80,000 patient-months of data are accumulated, during which 18 severe allergic reactions are recorded. (a) What is the expected number of reactions based on the pre-market rate? (b) Calculate the p-value for testing whether the post-market rate significantly exceeds the pre-market estimate (one-sided). Should the team escalate the safety signal?
Show answer
(a) Scaling the rate: λ = 1.5 × (80,000 / 10,000) = 1.5 × 8 = 12 expected reactions over 80,000 patient-months. (b) We observe X = 18. Under H₀: X ~ Poisson(12). The p-value = P(X ≥ 18 | λ = 12). Using the complement: P(X ≥ 18) = 1 − P(X ≤ 17). Computing the cumulative Poisson probability (via software or tables), P(X ≤ 17) ≈ 0.9370, so P(X ≥ 18) ≈ 0.0630. At the α = 0.05 significance level, 0.063 > 0.05, so the result is not quite statistically significant. However, pharmacovigilance typically uses more sensitive thresholds and considers clinical severity; the team should likely flag this as a potential safety signal for further investigation and Bayesian analysis, even though the frequentist test does not reject H₀ at 5%.

Question 5: CRITICAL THINKING

A researcher collects hospital admission counts for a rare autoimmune condition across 40 hospitals over one year. The sample mean is 3.2 admissions per hospital, and the sample variance is 7.8. (a) Assess whether a Poisson model is appropriate using the variance-to-mean ratio. (b) If the Poisson model is inadequate, propose an alternative model and explain its relationship to the Poisson distribution. (c) Discuss one biological mechanism that could produce the observed overdispersion.
Show answer
(a) The variance-to-mean ratio (VMR) = 7.8 / 3.2 = 2.4375. For a Poisson distribution, VMR should be approximately 1. A VMR of ~2.44 indicates substantial overdispersion, suggesting the Poisson model is inadequate. Formally, a chi-squared goodness-of-fit test with statistic (n−1) × VMR = 39 × 2.4375 = 95.1 on 39 degrees of freedom would strongly reject equidispersion. (b) The negative binomial distribution is the most natural alternative. It can be derived as a Poisson-gamma mixture: if the underlying rate λ varies across hospitals according to a gamma distribution, the marginal distribution of counts is negative binomial, which has Var = μ + μ²/θ > μ, accommodating overdispersion. (c) Overdispersion could arise from unobserved heterogeneity among hospitals: differences in catchment area demographics, diagnostic practices, environmental triggers, or referral patterns could cause some hospitals to have systematically higher or lower rates than others. This hospital-level variation inflates the overall variance beyond what a single Poisson rate would predict.

SUMMARY

Lesson Summary

Summary

The Poisson distribution is the foundational model in biostatistics for describing the probability of observing a given number of rare, independent events occurring in a fixed interval of time, space, or population exposure. Governed by a single parameter λ (lambda) — which equals both the mean and the variance — the distribution's probability mass function P(X = k) = (e⁻λ × λᵏ) / k! provides exact probabilities for any count k. Its four key assumptions — independence, constant rate, rarity, and proportionality — must be verified before application, most commonly via the variance-to-mean ratio (VMR) diagnostic.

In biostatistics and epidemiology, the Poisson distribution is applied to model disease incidence, mutation counts, adverse drug reactions, and cluster detection. When its equidispersion assumption is violated, extensions such as the negative binomial distribution and zero-inflated Poisson models offer greater flexibility. The Poisson distribution also serves as the gateway to Poisson regression (generalized linear models), the exponential distribution for inter-event times, and continuous-time Poisson processes — making it one of the most consequential distributions in the quantitative health sciences.

Varsity Tutors • Biostatistics • Poisson Distribution — Use Poisson distribution for rare events and incidence